A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT06132529
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (NIH), Arizona State University (Other)
260
2
72.9
130
1.8

Study Details

Study Description

Brief Summary

The purpose of this research study is to develop a model to help distinguish patients at high-risk for developing persistent post-traumatic headache from patients who experience headache recovery. Researchers will do this by comparing the brain images, clinical data, and speech of healthy controls to people who have been diagnosed with post-traumatic headache.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Brain Magnetic Resonance Imaging (MRI) Scan
  • Other: Speech Sample
  • Other: Electronic Daily Headache Diary

Study Design

Study Type:
Observational
Anticipated Enrollment :
260 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Biomarker Signature to Predict the Persistence of Post-traumatic Headache
Actual Study Start Date :
Jun 3, 2019
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Post-Traumatic Headache Group

Subjects diagnosed with having post-traumatic headache complete an MRI, speech sample, and electronic daily headache diary.

Diagnostic Test: Brain Magnetic Resonance Imaging (MRI) Scan
Imaging of the brain

Other: Speech Sample
Recorded reading aloud of pre-written words and sentences

Other: Electronic Daily Headache Diary
Headache diary to provide information about headaches experience that day.

Healthy Control Group

Subjects identified as health and not having any headaches will complete an MRI and speech sample.

Diagnostic Test: Brain Magnetic Resonance Imaging (MRI) Scan
Imaging of the brain

Other: Speech Sample
Recorded reading aloud of pre-written words and sentences

Outcome Measures

Primary Outcome Measures

  1. Prediction of post-traumatic headache recovery [6 years]

    Using questionnaires and fMRI

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Post-traumatic headache (PTH) and persistent post-traumatic headache (PPTH) will be diagnosed using the ICHD-3 diagnostic criteria for PTH attributed to mild traumatic brain injury (concussion).

  • For patients with PTH, only patients with new onset of PTH without history of PPTH will be included in the study.

  • A personal history of prior concussion and history of migraine are allowed according to ICHD-III diagnostic criteria.

  • Tension-type headaches on three or fewer days per month is allowed for healthy control subjects.

Exclusion Criteria:
  • History of moderate or severe traumatic brain injurie (TBI).

  • Prior history of gross anatomical change on imaging.

  • Contraindication to MRI, including but not limited to severe claustrophobia and/or presence of ferrous materials in the body.

  • Women who are pregnant, or believe that they might be pregnant. Although there are no known contraindications or risks associated with pregnancy and MRI, we will exclude pregnant women or women who believe that there might be a chance that they are pregnant.

  • History of concussion or more severe TBI.

  • History of migraine or other headaches.

  • The diagnosis for PTH and PPTH will be verified by Dr. Schwedt (co-investigator) a board-certified physician in Neurology and Headache Medicine. Presence of concussion will be verified using the Ohio State University TBI Identification Method, a standardized questionnaire assessing the lifetime history of TBI for an individual.

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Health Care System Phoenix Arizona United States 85012
2 Mayo Clinic Arizona Phoenix Arizona United States 85054

Sponsors and Collaborators

  • Mayo Clinic
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • Arizona State University

Investigators

  • Principal Investigator: Catherine Chong, PhD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Catherine (Cat) Chong, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT06132529
Other Study ID Numbers:
  • 19-005203
  • R61NS113315
First Posted:
Nov 15, 2023
Last Update Posted:
Nov 15, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2023